Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization
about
A comprehensive review of retinal gene therapyInhibition of glioma invasion by overexpression of pigment epithelium-derived factorRecombinant adeno-associated virus vector expressing angiostatin inhibits preretinal neovascularization in adult rats.Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasisOverexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.PEDF regulates vascular permeability by a γ-secretase-mediated pathway.Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival.Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathyGene transfer for neovascular age-related macular degeneration.Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy.Nanoparticle-based technologies for retinal gene therapyMolecular pathogenesis of retinal and choroidal vascular diseases.Retinal Gene Therapy: Current Progress and Future Prospects.AAV-mediated gene transfer for retinal diseases.Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice.Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.Use of growth factors for the treatment of Parkinson's disease.Microvascular modifications in diabetic retinopathy.Gene transfer for ocular neovascularization and macular edema.The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Gene delivery nanoparticles to modulate angiogenesis.Delivery and evaluation of recombinant adeno-associated viral vectors in the equine distal extremity for the treatment of laminitis.Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.Retinal gene therapy using adeno-associated viral vectors: multiple applications for a small virus.In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy.Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases.Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice.Activation of Complement by Pigment Epithelium-Derived Factor in Rheumatoid Arthritis.2006 Council Lecture: Lancelot to the rescue: realizing the promise of genomic medicine.
P2860
Q27023914-E85A76E7-3F56-4559-BF1F-87450BB23E0BQ28252870-F41CC536-1EF8-41B9-A5DD-273FB7447624Q31139438-1F35916C-E58F-4069-8ADF-46EDBA15C946Q33285670-6172F586-5C7D-488D-A99F-150FD1AC5F5FQ33397385-DA434FE8-8841-4729-A1BC-F5E738982A6BQ33640617-569C24E6-D495-4AB4-9E6B-5D8CB6625232Q33808055-7B75D38B-68BB-44B2-862F-E13364ABB7B7Q33939170-D27E4760-E94E-43A6-96F1-9E98CBAD31BEQ34281455-15631F7F-9A6D-4F8B-BB13-8F2E7D2A05C9Q34354096-E9293720-B63F-4A89-96FD-2EBF66698493Q34387956-608E69E8-0560-4F6F-89E0-9CADF02047ABQ34843778-659CB30C-0A57-429E-88B6-34E483652AD9Q35034418-EBDA9A2E-D2D8-41F5-8915-07E3C3961867Q35188790-B5492752-61A6-4656-BCE2-E3171A1EDB53Q35843512-C0AB7588-1BB1-42E2-BD33-5BAEA9F49001Q36296789-5D2528F5-7F7C-429C-B303-038C51FEA2F3Q36306263-50396194-A7F1-402E-A84B-E5C9742BCCFAQ36708300-6B81702A-34F5-4AB7-9B4A-F2AB57BBBA9EQ36904857-780AF51E-84D7-47D0-A5E5-F246BFC52CEEQ37086112-9782F255-917F-4517-AB0F-8FEEBFA85E05Q37762259-710F16B7-54CC-4F3F-ADBB-A3AC7D4CBD24Q37879581-4BC9A83E-E06D-430B-B32C-878B4368088FQ37954532-9A87EFF3-B919-47D5-BE2C-BF91F5042DC9Q38103913-44AF5EF4-506C-4B11-AE19-BDFCA8675481Q39027588-51101F51-4434-46FF-895F-B5A5C576FA02Q40337400-B6554EEC-CC5A-45BC-925E-51013FDC6254Q41370150-1E3599BA-6846-4039-89DE-A1E7C41ED3D5Q42007962-85DEBEE7-1CA4-42C1-94FD-9849453647DDQ45869907-66F3424C-5CE6-42FC-ADED-9F6CD7FA962BQ45871728-A2D07D90-478C-4215-AEAB-388E0FEB1B8BQ46432753-E33C0DBB-B22A-48A9-BC29-01380C2B19B8Q48241059-D4A09C3C-B27D-4D6F-B079-A1C5928962B8Q48555506-9A130649-4D47-4EAB-844A-02EF5473AFC0
P2860
Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Adeno-associated virus type-2 ...... uce retinal neovascularization
@ast
Adeno-associated virus type-2 ...... uce retinal neovascularization
@en
type
label
Adeno-associated virus type-2 ...... uce retinal neovascularization
@ast
Adeno-associated virus type-2 ...... uce retinal neovascularization
@en
prefLabel
Adeno-associated virus type-2 ...... uce retinal neovascularization
@ast
Adeno-associated virus type-2 ...... uce retinal neovascularization
@en
P2093
P2860
P356
P1476
Adeno-associated virus type-2 ...... uce retinal neovascularization
@en
P2093
Brian J Raisler
Denis Beliaev
Kenneth I Berns
Maria B Grant
William W Hauswirth
P2860
P304
P356
10.1073/PNAS.122247299
P407
P577
2002-06-18T00:00:00Z